PMS-FLUTICASONE HFA

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 8ef9f4e9f6fc00ac
Drug Approval Canada Name: PMS-FLUTICASONE HFA
Product Name: PMS-FLUTICASONE HFA
Status: Marketed
Status Date: 2022-04-18
Original Market Date: 2022-04-18
Din: 02503123
Drug Class: Human
Dosage Form: Metered-Dose Aerosol
Route Of Administration: Oral , Inhalation
Schedule: Prescription
Ahfs: 68:04.00
Atc Original: R03BA05 FLUTICASONE
Atc Name: r 03 ba 05
Aig Number: 0124685004
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

FLUTICASONE PROPIONATE

125 MCG / ACT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8ef9f4e9f6fc00ac

Type

Standard